Advantage 40 mg Spot-on solution for Small Cats and Small Pet Rabbits

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Imidacloprid

Διαθέσιμο από:

Bayer Limited

Φαρμακολογική κατηγορία (ATC):

QP53AX17

INN (Διεθνής Όνομα):

Imidacloprid

Δοσολογία:

40 mg/pipette

Φαρμακοτεχνική μορφή:

Spot-on solution

Τρόπος διάθεσης:

POM: Prescription Only Medicine as defined in relevant national legislation

Θεραπευτική ομάδα:

Cats, Rabbits

Θεραπευτική περιοχή:

imidacloprid

Θεραπευτικές ενδείξεις:

Ectoparasiticide

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2012-02-24

Αρχείο Π.Χ.Π.

Health Products Regulatory Authority
19 December 2017
CRN000WFR
Page 1 of 7
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 40 mg Spot-on solution for Small Cats and Small Pet Rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.4 ml pipette contains:
ACTIVE SUBSTANCE:
Imidacloprid40 mg
EXCIPIENT(S):
Butylhydroxytoluene (E 321)0.4 mg
Benzyl alcohol (E 1519)332.8 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution
Clear yellow to slightly brownish solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and petrabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats of less than 4 kg:
Prevention and treatment of flea _(Ctenocephalides felis)
_infestations
For pet rabbits of less than 4 kg:
Treatment of flea infestations
Fleas are killed within one day following treatment. One treatment
prevents further
flea infestation for three to four weeks on cats and up to one week on
pet rabbits.
The product can be used as part of a treatment strategy for the
control of Flea
Allergy Dermatitis (FAD) in cats, where this has been previously
diagnosed by a
veterinary surgeon.
4.3 CONTRAINDICATIONS
Health Products Regulatory Authority
19 December 2017
CRN000WFR
Page 2 of 7
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not use in case of hypersensitivity to the active substance or to
any of the
excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Re-infestation from emergence of new fleas in the environment may
continue to
occur for six weeks or longer after treatment is initiated. More than
one treatment
may therefore be required, depending on the level of fleas in the
environment. To aid
reduction in environmental challenge, the additional use of a suitable
environmental
treatment against adult fleas and their developing stages is
recommended. In order
to reduce further the environmental challenge, it is recommended that
all cats and
rabbits in the household are treated. Treatment of nursing